Allicin inhibits blood vessel growth and downregulates Akt phosphorylation and actin polymerization

Nutrition and Cancer

Volumn 60, Issue 3, 2008, Pages 412-420

  Sela, Uri ^a,d   Brill, Alexander ^b   Kalchenko, Vyacheslav ^c   Dashevsky, Olga ^b   Hershkoviz, Rami ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALLICIN; BASIC FIBROBLAST GROWTH FACTOR; PROTEIN KINASE B; VASCULOTROPIN;

ACTIN POLYMERIZATION; ANIMAL CELL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENDOTHELIUM CELL; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT;

ACTINS; ANIMALS; AORTA; CATTLE; CELL MOVEMENT; CELLS, CULTURED; CYTOSKELETON; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; HUMANS; MALE; MICROTUBULES; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; SULFINIC ACIDS; TUBULIN;

EID: 42649109037     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580701733083     Document Type: Article

References (38)

1. Carmeliet P: Mechanisms of angiogenesis and arteriogenesis. Nat Med 6, 389-39, 2000.
2. Gong C, Stoletov, KV, and Terman BI: VEGF treatment induces signaling pathways that regulate both actin polymerization and depolymerization. Angiogenesis 7, 313-321, 2004
3. Carmeliet P: Angiogenesis in health and disease. Nat Med 9, 653-660, 2003.
4. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100, 57-70, 2000.
5. Imhof BA and Aurrand-Lions M: Angiogenesis and inflammation face off. Nat Med 12, 171-172, 2006.
6. Danese S, Sans M, de la Motte C, Graziani C, West G, et al.: Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology 130, 2060-2073, 2006.
7. Koch AE: Angiogenesis as a target in rheumatoid arthritis. Ann Rheum Dis 62(2Suppl), 60-67, 2003.
8. Stoll A and Seebeck E: Chemical investigation on alliin, the specific principle of garlic. Adv Enzymol 11, 377-400, 1951.
9. Uchida Y, Takahashi T, and Sato N: The characteristics of the antibacterial activity of garlic (author's trans.). Jpn J Antibiot 28, 638-642, 1975.
10. Harris JC, Cottrell SL, Plummer S, and Lloyd D: Antimicrobial properties of Allium sativum (garlic). Appl Microbiol Biotechnol 57, 282-286, 2001.
11. Lau BH: Suppression of LDL oxidation by garlic. J Nutr 131, 985S-988S, 2001.
12. Abramovitz D, S Gavri, D Harats, H Levkovitz, D Mirelman, et al.: Allicin-induced decrease in formation of fatty streaks (atherosclerosis) in mice fed a cholesterol-rich diet. Coron Artery Dis 10, 515-519, 1999.
13. Hirsch K, M Danilenko, J Giat, T Miron, A Rabinkov, et al.: Effect of purified allicin, the major ingredient of freshly crushed garlic, on cancer cell proliferation. Nutr Cancer 38, 245-254, 2000.
14. Sela U, S Ganor, I Hecht, A Brill, T Miron, et al.: Allicin inhibits SDF-1alpha-induced T cell interactions with fibronectin and endothelial cells by down-regulating cytoskeleton rearrangement, Pyk-2 phosphorylation and VLA-4 expression. Immunology 111, 391-399, 2004.
15. Xiao D, M Li, A Herman-Antosiewicz, J Antosiewicz, H Xiao, et al.: Diallyl trisulfide inhibits angiogenic features of human umbilical vein endothelial cells by causing Akt inactivation and down-regulation of VEGF and VEGFR2. Nutr Cancer 55, 94-107, 2006.
16. Mousa AS. and SA Mousa: Anti-angiogenesis efficacy of the garlic ingredient alliin and antioxidants: role of nitric oxide and p53. Nutr Cancer 53, 104-110, 2005.
17. Miron T, H SivaRama, A Rabinkov, D Mirelman, and M Wilchek: A method for continuous production of allicin using immobilized alliinase. Anal Biochem 351, 152-154, 2006.
18. Miron T, A Rabinkov, D Mirelman, L Weiner, and M Wilchek: A spectrophotometric assay for allicin and alliinase (Alliin lyase) activity: reaction of 2-nitro-5-thiobenzoate with thiosulfinates. Anal Biochem 265, 317-325, 1998.
19. Nicosia RF and A Ottinetti: Growth of microvessels in serum-free matrix culture of rat aorta: a quantitative assay of angiogenesis in vitro. Lab Invest 63, 115-122, 1990.
20. Brill A, O Dashevsky, J Rivo, Y Gozal, and D Varon: Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovasc Res 67, 30-38, 2005.
21. Buser R, R Montesano, I Garcia, P Dupraz, and MS Pepper: Bovine microvascular endothelial cells immortalized with human telomerase. J Cell Biochem 98, 267-286, 2006.
22. Reinhart-King CA, M Dembo, and DA Hammer: The dynamics and mechanics of endothelial cell spreading. Biophys J 89, 676-689, 2005.
23. Hubner K, G Fuhrmann, LK Christenson, J Kehler, R Reinbold, et al.: Derivation of oocytes from mouse embryonic stem cells. Science 300, 1251-1256, 2003.
24. Morales-Ruiz M, D Fulton, G Sowa, LR Languino, Y Fujio, et al.: Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt. Circ Res 86, 892-896, 2000.
25. Ferrara N, HP Gerber, and J LeCouter: The biology of VEGF and its receptors. Nat Med 9, 669-676, 2003.
26. Browne CD, EJ Hindmarsh, and JW Smith: Inhibition of endothelial cell proliferation and angiogenesis by orlistat, a fatty acid synthase inhibitor. FASEB J 20, 2027-2035, 2006.
27. Borthwick GM, AS Johnson, M Partington, J Burn, R Wilson, et al.: Therapeutic levels of aspirin and salicylate directly inhibit a model of angiogenesis through a Cox-independent mechanism. FASEB J 20, 2009-2016, 2006.
28. Xiao Z, Y Wang, L Lu, Z Li, Z Peng, et al.: Anti-angiogenesis effects of meisoindigo on chronic myelogenous leukemia in vitro. Leuk Res 30, 54-59, 2006.
29. Matsuura N, Y Miyamae, K Yamane, Y Nagao, Y Hamada, et al.: Aged garlic extract inhibits angiogenesis and proliferation of colorectal carcinoma cells. J Nutr 136, 842S-846S, 2006.
30. Schmidt A and MN Hall: Signaling to the actin cytoskeleton. Annu Rev Cell Dev Biol 14, 305-338, 1998.
31. Heng BC, H Liu, and T Cao: Can the high nuclear to cytoplasmic ratio of human embryonic stem cells make them more vulnerable to physical stress encountered with bulk-passage protocols? Med Hypotheses 64, 1242-1243, 2005.
32. Liu ZJ, M Xiao, K Balint, A Soma, CC Pinnix, et al.: Inhibition of endothelial cell proliferation by Notch1 signaling is mediated by repressing MAPK and PI3K/Akt pathways and requires MAML1. FASEB J 20, 1009-1011, 2006.
33. Papapetropoulos A, D Fulton, K Mahboubi, RG Kalb, DS O'Connor, et al.: Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J Biol Chem 275, 9102-9105, 2000.
34. Dimmeler S and AM Zeiher: Akt takes center stage in angiogenesis signaling. Circ Res 86, 4-5, 2000.
35. Rabinkov A, T Miron, L Konstantinovski, M Wilchek, D Mirelman, et al.: The mode of action of allicin: trapping of radicals and interaction with thiol containing proteins. Biochim Biophys Acta 1379, 233-244, 1998.
36. Miron T, A Rabinkov, D Mirelman, M Wilchek, and L Weiner: The mode of action of allicin: its ready permeability through phospholipid membranes may contribute to its biological activity. Biochim Biophys Acta 1463, 20-30, 2000.
37. Sundaram SG and JA Milner: Impact of organosulfur compounds in garlic on canine mammary tumor cells in culture. Cancer Lett 74, 85-90, 1993.
38. Bruck R, H Aeed, E Brazovsky, T Noor, and R Hershkoviz: Allicin, the active component of garlic, prevents immune-mediated, concanavalin A-induced hepatic injury in mice. Liver Int 25, 613-621, 2005.